Gitlab Inc.: Form 10-K for the period ended Jan 31, 2025
Filed with the SEC on Mar 21, 2025 and accepted by EDGAR at Mar 21, 2025, 16:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-02-01 to 2025-01-31 | $759.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2024-02-01 to 2025-01-31 | $85.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2024-02-01 to 2025-01-31 | $674.1m | us-gaap:GrossProfit |
| Research and development | 12 months2024-02-01 to 2025-01-31 | $239.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2024-02-01 to 2025-01-31 | −$142.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-02-01 to 2025-01-31 | −$76.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-02-01 to 2025-01-31 | −$6.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-02-01 to 2025-01-31 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-02-01 to 2025-01-31 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-02-01 to 2025-01-31 | 160,580,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-02-01 to 2025-01-31 | −$64.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-02-01 to 2025-01-31 | $3.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-01-31 | $227.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-01-31 | $1.34bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-01-31 | $1.40bn | us-gaap:Assets |
| Current liabilities | At period end2025-01-31 | $545.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-01-31 | $578.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-01-31 | $775.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-014344. Last ingested by Listed: Oct 30, 2026, 16:31 ET. Listed shows no prices and gives no investment advice.